# CEL Sci Corp: Form 10-Q/A for the period ended Mar 31, 2020

- Company: [CEL Sci Corp](/companies/cvm.md) (CIK 725363)
- Form: 10-Q/A
- Filed: 2020-12-30
- Accepted by EDGAR: Dec 30, 2020, 22:17 ET
- Period: 2020-03-31
- Accession: 0001654954-20-014034
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/725363/000165495420014034/cvm_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/725363/000165495420014034/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $4.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2019-10-01 to 2020-03-31 | $8.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | −$6.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2019-10-01 to 2020-03-31 | −$13.6m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$9.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-10-01 to 2020-03-31 | −$14.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2019-10-01 to 2020-03-31 | −$0.41 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.25 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2019-10-01 to 2020-03-31 | −$0.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 36,165,050 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2019-10-01 to 2020-03-31 | 35,621,711 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2019-10-01 to 2020-03-31 | −$8.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2019-10-01 to 2020-03-31 | $752.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-03-31 | $14.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $15.8m | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $36.6m | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $5.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $22.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-03-31 | $14.1m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/725363/000165495420014034/cvm_10qa.htm

Filed Dec 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001654954-20-014034. Last ingested by Listed: Oct 24, 2026, 14:55 ET. No prices; not investment advice.
